Related Experiment Video
Updated: Jan 13, 2026
Author Spotlight: Understanding and Detecting Environmental Antimicrobial Resistance by Combining Culture-Based Techniques and Genomics
Published on: July 19, 2024
Trends and significance of antimicrobial resistance in respiratory pathogens
1Department of Microbiology, Mount Sinai Hospital and the Toronto Medical Laboratories, University of Toronto, Toronto, Canada.
Abstract:
Although we have witnessed a dramatic increase in the prevalence of antimicrobial resistance in respiratory pathogens over the past few years, resistance has infrequently been associated with clinical failures. However, as the prevalence and degree of resistance increases in the beta-lactams and the fluoroquinolones, newly approved for respiratory infections, failures are likely to occur.
Insights
Antimicrobial resistance in respiratory pathogens is rising but rarely causes treatment failure. However, increasing resistance to beta-lactams and fluoroquinolones may lead to future clinical failures.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Rising prevalence of antimicrobial resistance in respiratory pathogens.
- Infrequent association between antimicrobial resistance and clinical failures historically.
- Emergence of resistance in key antibiotic classes used for respiratory infections.
Purpose of the Study:
- To analyze the relationship between antimicrobial resistance and clinical outcomes in respiratory pathogens.
- To assess the potential impact of increasing resistance on treatment efficacy.
- To highlight the growing threat of resistance in beta-lactams and fluoroquinolones.
Main Methods:
- Review of recent epidemiological data on antimicrobial resistance.
- Analysis of clinical outcomes correlated with pathogen resistance profiles.
- Evaluation of trends in resistance for specific antibiotic classes.
Main Results:
- Antimicrobial resistance in respiratory pathogens has increased significantly.
- Clinical failures directly attributed to resistance have been infrequent to date.
- Growing resistance is noted in beta-lactam and fluoroquinolone antibiotics.
Conclusions:
- While clinical failures are currently rare, rising antimicrobial resistance poses a future risk.
- Increased resistance in beta-lactams and fluoroquinolones may precipitate treatment failures.
- Continued surveillance and development of new therapeutic strategies are crucial.
